Table 3.
Value | Global quality of life (QL) improvement | EORTC QLQ-C30 Summary Score improvement | ||||
---|---|---|---|---|---|---|
OR | 95% CI | p-value | OR | 95% CI | p-value | |
Multiivariable model | ||||||
Preoperative Global Quality of Life (QL) | 0.94 | 0.93–0.94 | < 0.001 | 0.88 | 0.87–0.89 | < 0.001 |
Fulfilled trifecta criteria at 24 months after surgery | 1.91 | 1.59–2.29 | < 0.001 | 1.61 | 1.27–2.04 | < 0.001 |
CAPRA-S risk group (high risk vs. low risk [REF]) | 0.60 | 0.46–0.78 | < 0.001 | 0.67 | 0.48–0.94 | 0.02 |
Surgery complications (CDC ≥ 3b vs. 0–3a[REF]) | 0.49 | 0.24–0.99 | 0.048 | 0.94 | 0.42–2.10 | 0.9 |
Univariable model | ||||||
Preoperative Global Quality of Life (QL) | 0.94 | 0.93–0.94 | < 0.001 | 0.89 | 0.88–0.90 | < 0.001 |
Fulfilled trifecta criteria at 24 months after surgery | 1.76 | 1.50–2.05 | < 0.001 | 1.53 | 1.25–1.87 | < 0.001 |
CAPRA-S risk group (high risk vs. low risk [REF]) | 0.63 | 0.51–0.79 | < 0.001 | 0.68 | 0.52–0.91 | 0.008 |
Surgery complications (CDC ≥ 3b vs. 0–3a[REF]) | 0.64 | 0.38–1.07 | 0.09 | 1.39 | 0.79–2.46 | 0.3 |
Significant values are in italics.
CAPRA-S the postsurgical Cancer of the Prostate Risk Assessment score, CDC Clavien–Dindo classification, CI confidence interval, OR odds ratio.